Author of the publication

Standardization and Validation of Spinal Nerve Ligation Model of Neuropathic Pain in Rats

, , , and . Pharmacologia, 6: 160, (2015)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

No persons found for author name Talaviya, Praful
add a person with the name Talaviya, Praful
 

Other publications of authors with the same name

Standardization and Validation of Spinal Nerve Ligation Model of Neuropathic Pain in Rats, , , and . Pharmacologia, 6: 160, (2015)Multiple educational programs improves glycemic control, quality of life with diminishing the impact of diabetes in poorly controlled type 1 diabetics, , , and . Diabetes & Metabolic Syndrome: Clinical Research & Reviews, (2017)Anticancer approach with natural product. International Journal of Pharmaceutical Sciences and Research, 2 (10): 2514 (2011)Prevalence of obesity and overweight in housewives and its relation with household activities and socio-economical status, , , , , , and . Journal of Obesity and Metabolic Research, 1 (1): 20 (2014)A Review on Recurrent miscarriage, and . Journal of Pharmacy Research, 4 (11): 4243--8 (2011)Anti-inflammatory activity of four fractions of ethanolic extract of Crotalaria burhia Buch.-Ham. root in rats, , , , and . National Journal of Physiology, Pharmacy and Pharmacology, 4 (3): 213 (2014)Pregnancy outcome and glycemic control in women with type 1 diabetes: A retrospective comparison between CSII and MDI treatment, , , , , , , and . Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 7 (2): 68--71 (April 2013)Evaluation of Antitumor Activity of Crotalaria Burhia Buch.-Ham. Roots Against Ehrlich’s Ascites Carcinoma Treated Mice, , , , and . Indian J Physiol Pharmacol, 62 (2): 259--266 (2018)A review on: potential antidiabetic herbal medicines, , , , , and . International Journal of Pharmaceutical Sciences and Research, 5 (2): 302 (2014)Review on special emphasis of bortezomib on relapsed/refractory myeloma, , , and . International Journal of Research in Medical Sciences, 2 (4): 1278--1282 (2017)